Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03340701Phase 1Completed
Phase 1, open-label, single-arm trial of progesterone in pregnancy, sponsored by Thomas Jefferson University. Primary endpoint: Pharmacokinetic model at 24 hours. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03340701.